2'-Deoxycytidine Bulk Price Global Manufacturer 2026
- Market Outlook: Demand for high-purity CAS 951-77-9 is projected to rise through 2026 driven by antiviral and oncology research.
- Procurement Strategy: Volume-based pricing tiers significantly reduce unit costs for industrial-scale pharmaceutical intermediate sourcing.
- Quality Assurance: Leading suppliers provide full COA, SDS, and COO documentation to ensure compliance with GMP standards.
The global pharmaceutical landscape is shifting towards more complex nucleoside-based therapies, driving significant demand for key building blocks like 2'-Deoxycytidine. As we approach 2026, procurement managers and process chemists must navigate fluctuating raw material costs and stringent quality requirements. Understanding the bulk price dynamics for this critical pharmaceutical intermediate is essential for maintaining supply chain stability and cost-efficiency in drug development.
As a premier global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. recognizes that accurate forecasting of material costs is vital for long-term project viability. This analysis provides a technical and commercial overview of sourcing 2'-Deoxycytidine at an industrial scale, focusing on purity specifications, synthesis scalability, and logistics.
Technical Specifications and Chemical Properties
2'-Deoxycytidine, often referred to as Deoxycytidine or the dC nucleoside, is a fundamental component in the synthesis of DNA. Its chemical formula is C9H15N3O5, and it carries the CAS Registry Number 951-77-9. In industrial applications, the compound is frequently handled as the 2'-Deoxycytidine monohydrate form to ensure stability during storage and transport.
For large-scale manufacturing, the physical state and purity profile are paramount. High-grade material typically presents as a white to off-white crystalline powder. The following table outlines the critical quality attributes required for pharmaceutical-grade procurement:
| Parameter | Specification Standard | Industrial Application |
|---|---|---|
| Assay (Purity) | >98.0% to >99.0% | Ensures minimal impurities in downstream synthesis. |
| Appearance | White or Off-White Powder | Visual inspection for contamination. |
| Loss on Drying | <0.5% | Critical for stoichiometric accuracy in reactions. |
| Heavy Metals | <10 ppm | Compliance with safety regulations for human therapeutics. |
| Documentation | COA, SDS, COO | Required for customs and regulatory audits. |
Synthesis Routes and Manufacturing Process
The manufacturing process for 2'-Deoxycytidine involves precise chemical transformations to achieve the necessary industrial purity. Common synthesis routes include the condensation of protected sugar derivatives with cytosine bases, followed by deprotection steps. The efficiency of this synthesis route directly impacts the bulk price.
High-yield reactions are essential for cost-effective production. Manufacturers optimize reaction conditions to minimize byproducts and maximize the recovery of the target nucleoside analog. Process chemists focus on scalable methodologies that maintain consistency across large batches. This ensures that the material performs reliably in subsequent coupling reactions used to create oligonucleotides or antiviral agents.
Commercial Applications and Market Demand
The utility of this compound extends across several high-value sectors. As a primary DNA building block, it is indispensable in genetic engineering and molecular biology. However, the bulk of the industrial demand stems from pharmaceutical development.
- Antiviral Research: The compound is explored for potential therapies against viruses such as HIV and hepatitis, where nucleoside analogs inhibit viral replication.
- Cancer Treatment: Researchers investigate its role in chemotherapy regimens, as it can be incorporated into DNA to affect cancer cell proliferation.
- Genetic Studies: It is used in studies involving DNA replication and repair mechanisms, providing insights into genetic disorders and aging.
- Pharmaceutical Development: The compound is a key ingredient in the formulation of new medications targeting various metabolic pathways.
Bulk Pricing Trends and Procurement Strategy for 2026
Pricing for fine chemicals is rarely static. For 2026, buyers should anticipate volume-based pricing tiers that reward larger commitments. Retail packs, often sold in gram quantities by laboratory suppliers, carry a significant premium per unit weight. In contrast, industrial procurement focuses on kilogram and multi-kilogram scales.
When evaluating suppliers for 2'-Deoxycytidine, buyers should prioritize manufacturers who offer transparent cost structures based on order volume. Key factors influencing the final bulk price include:
- Raw Material Availability: Fluctuations in the cost of precursor sugars and bases.
- Production Capacity: Facilities capable of multi-ton scale production can offer more competitive rates.
- Quality Control: Higher purity grades requiring extensive chromatography or recrystallization may command higher prices but reduce downstream processing costs.
- Logistics: Global shipping logistics and customs duties impact the landed cost significantly.
Quality Assurance and Regulatory Compliance
In the pharmaceutical industry, documentation is as critical as the chemical itself. A reliable supplier must provide a comprehensive Certificate of Analysis (COA) for every batch. The COA confirms the product's properties, including chemical composition, physical state, purity, and storage requirements. It also details acceptable quality ranges and the product's intended applications.
Furthermore, Safety Data Sheets (SDS) provide comprehensive safety information on handling, storage, and disposal of the product. For international trade, Certificates of Origin (COO) confirm the country where the product was manufactured. This certificate may be required for customs, trade, and regulatory compliance. Adherence to GMP standards ensures that the manufacturing environment meets the rigorous hygiene and process control necessary for human drug production.
Conclusion
Securing a stable supply of high-quality 2'-Deoxycytidine is a strategic imperative for pharmaceutical manufacturers planning for 2026 and beyond. By focusing on industrial purity, verified synthesis routes, and transparent bulk pricing, companies can mitigate supply chain risks.
NINGBO INNO PHARMCHEM CO.,LTD. stands ready to support global partners with consistent supply and technical expertise. Partnering with an established manufacturer ensures access to reliable biochemical reagent sources, full documentation support, and competitive pricing structures tailored for large-scale industrial needs.